Page 5 - சிறப்பு அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சிறப்பு அதிகாரம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சிறப்பு அதிகாரம் Today - Breaking & Trending Today

Business Scoop » PHARMAC To Fund New Diabetes Medicines With Amended Special Authority Criteria

Press Release – PHARMAC
PHARMAC has approved funding for two new medicines with substantial health benefits for around 53,000 New Zealanders with type 2 diabetes. Read this media release in Te Reo Mori People with high-risk type 2 diabetes, who meet the funding criteria, …
PHARMAC has approved funding for two new medicines with substantial health benefits for around 53,000 New Zealanders with type 2 diabetes.
People with high-risk type 2 diabetes, who meet the funding criteria, will be able to access funded empagliflozin (with or without metformin) from 1 February 2021. They will also be able to get funded dulaglutide once it has Medsafe approval.
“People with diabetes, their whānau and health professionals told us that there is a need for these effective medicines to be funded to help manage the growing health problem of type 2 diabetes in Aotearoa,” says PHARMAC’s chief executive Sarah Fitt. ....

New Zealand , New Zealanders , Sarah Fitt , Press Release , Special Authority , புதியது ஜீலாந்து , சாரா பொருத்தம் , ப்ரெஸ் வெளியீடு , சிறப்பு அதிகாரம் ,

Pharmac to fund new diabetes medicines with amended Special Authority criteria

+Undoctored
Media release from Pharmac
Monday 21 December 2020, 04:05 PM
PHARMAC has approved funding for two new medicines with substantial health benefits for around 53,000 New Zealanders with type 2 diabetes.
People with high-risk type 2 diabetes, who meet the funding criteria, will be able to access funded empagliflozin (with or without metformin) from 1 February 2021. They will also be able to get funded dulaglutide once it has Medsafe approval.
“People with diabetes, their whānau and health professionals told us that there is a need for these effective medicines to be funded to help manage the growing health problem of type 2 diabetes in Aotearoa,” says PHARMAC’s chief executive Sarah Fitt. ....

New Zealand , New Zealanders , Sarah Fitt , Special Authority , புதியது ஜீலாந்து , சாரா பொருத்தம் , சிறப்பு அதிகாரம் ,